Antler, Venture Catalysts, Hatcher+, and We Founder Circle organized a seed round in which biotech startup Cellivate Technologies raised $1 million.
According to a news statement from Cellivate, the money will be used to quicken its research and development activities, increase the volume of its creative items produced, and broaden its customer base.
Cellivate, founded by Viknish Krishnan Kutty, is creating cutting-edge solutions to major problems in biomanufacturing and cell culture. The company’s flagship products include a revolutionary cell-based serum intended to replace fetal bovine serum and sophisticated microcarriers for accelerating cell development.
Based on market research, the cell culture market is anticipated to reach $33 billion by 2030, with a particular focus on microcarriers and serum.
According to Cellivate, their sophisticated microcarriers and cell-based serum substitutes could save expenses, boost productivity, and solve moral dilemmas with cell culture procedures. Technological developments in cell culture and biomanufacturing will lessen society’s reliance on animal slaughter because cells can be used to produce a number of goods and ingredients that are traditionally produced from animals.
Using sustainable cell technology, Cellivate technology offers cell-based alternatives to animal slaughter. The cost of its in-house solutions is far lower than that of what is now on the market. The three industries in which the company currently serves clients are skincare, cultivated leather, and cultivated meat. Cellivate has already gained a lot of traction in this market and is in a unique position to satisfy the need for these components.
Cell-based sustainable leathers, in contrast to other kinds of bio-based leather substitutes, are made invitro from the rebuilt skin of exotic animals.
Cellivate, being a leader in cell cultivation, is cultivating cultured leather through its array of goods, instruments, methods, and technology.
The current practices of animal husbandry can be replaced with sustainable meat from crops. The US$1.6 trillion meat market is about to be upended by the cultured meat sector, which is expected to be valued US$1.66 billion by 2031 and $11.13 billion by 2041.
Cellivate is collaborating with companies who raise meat to assist them in expanding and increasing their cell cultures.
Read More: Click Here
